Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
This content is provided by Berry van Wijk
Berry van Wijk specialises in insurance law and liability issues. She advises and litigates in the fields of regulatory law, reinsurance, life and non-life insurance, distribution of insurance, the transfer of portfolios and the liability of insurers for their products.
Berry advises on the development of new life and non-life insurance products as well as new distribution forms. She helps clients in their contacts with the main Dutch regulators, the Dutch Central Bank (DNB) and the Netherlands Authority for the Financial Markets (AFM), and assists them with the implementation of regulatory requirements in the Netherlands. Berry further advises on the regulatory component of M&A transactions in the insurance industry.
Berry is a trusted adviser to the legal counsel and board members of several insurance companies. She is a daily board member of the Association for Insurance Sciences (Vereniging voor Verzekeringswetenschap) and member of the Advisory Committee on Insurance of the Dutch Bar Association (Orde van Advocaten). She is also a member of the Advisory Council of the Albert Schweitzer hospital and of the VNAB (Dutch Insurance Exchange Association).
Berry is a lecturer at the University of Amsterdam and Erasmus University.